Arcutis Biotherapeutics (ARQT)
Develops ZORYVE topical treatments for plaque psoriasis, atopic dermatitis, and seborrheic dermatitis.
$26.30
vs last close−1.48 (−5.34%)
Something off on this page? Send us feedback.
Next report
Oct 27, 26
in 34 days
EPS estimate
$0.17
Revenue estimate
$141.7M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26May '26Aug '26Oct '26
Reported−$0.09−$0.20−$0.13$0.06$0.13−$0.09$0.11Pending
Estimate−$0.28−$0.21−$0.18−$0.10$0.03−$0.02$0.06$0.17
Surprise+67.9%+4.8%+27.8%+160.0%+333.3%−350.0%+99.7%—
RevenueReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26May '26Aug '26Oct '26
Reported$71.4M$65.8M$81.5M$99.2M$129.5M$105.4M$129.9MPending
Estimate$60.5M$72.7M$80.6M$110.8M$113.1M$103.7M$118.9M$141.7M
Surprise+17.9%−9.4%+1.1%−10.4%+14.5%+1.7%+9.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.30 | — | — |
| Sep 2027 | $0.28 | — | — |
| Jun 2027 | $0.22 | — | — |
| Mar 2027 | $0.08 | — | — |
| Dec 2026 | $0.26 | — | — |
| Oct 2026 | $0.17 | — | — |
| Aug 2026 | $0.06 | $0.11 | +99.7% |
| May 2026 | −$0.02 | −$0.09 | −350.0% |
| Feb 2026 | $0.03 | $0.13 | +333.3% |
| Oct 2025 | −$0.10 | $0.06 | +160.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Jan 2020 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.30 | — | — | $177.5M | — | — | — |
| Sep 2027 | $0.28 | — | — | $171.7M | — | — | — |
| Jun 2027 | $0.22 | — | — | $157.7M | — | — | — |
| Mar 2027 | $0.08 | — | — | $137.7M | — | — | — |
| Dec 2026 | $0.26 | — | — | $160.1M | — | — | — |
| Oct 27, 2026 | $0.17 | — | — | $141.7M | — | — | — |
| Aug 5, 2026 | $0.06 | $0.11 | +99.7% | $118.9M | $129.9M | +9.3% | −2.5% |
| May 6, 2026 | −$0.02 | −$0.09 | −350.0% | $103.7M | $105.4M | +1.7% | −14.5% |
| Feb 25, 2026 | $0.03 | $0.13 | +333.3% | $113.1M | $129.5M | +14.5% | +5.8% |
| Oct 28, 2025 | −$0.10 | $0.06 | +160.0% | $110.8M | $99.2M | −10.4% | +27.0% |
| Aug 6, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 25, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 14, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 3, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 22, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 4, 2021 | |||||||
| Feb 16, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 19, 2020 | |||||||
| Jan 31, 2020 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |